At Novartis, we are driven by a single mission: to discover new ways to improve and extend people’s lives. Through science-based innovation we address some of society’s most challenging healthcare issues. Working to discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Novartis focuses on innovative patent-protected medicines, generics and eye care products – segments where we have global reach and strong relations with our customers. Research and development (R&D) sits at the core of our business and central to our strategy. Our global organizations for manufacturing, business services and other functions help increase efficiency and promote excellence.
The Innovative Medicines division has two business units:
-Novartis Pharmaceuticals focuses on patented treatments in the areas of cardiovascular, respiratory, neuroscience, ophthalmology, and immunology and dermatology.
-Novartis Oncology is focused on treatments for a variety of cancers and rare diseases.
Sandoz : Sandoz offers patients and healthcare professionals high-quality, affordable generics and biosimilars. The Sandoz portfolio also includes some mature products that were transferred from the Innovative Medicines division in 2016.
Alcon: With its Surgical and Vision Care businesses, Alcon offers one of the world’s widest selections of eye care devices – from sophisticated equipment for delicate eye surgery to a wide portfolio of advanced contact lenses.
Functional organizations with a global reach:
-Novartis Institutes for BioMedical Research (NIBR): NIBR focuses on discovering new drugs that can change the practice of medicine.
-Global Drug Development (GDD): GDD oversees the development of new medicines.
-Novartis Technical Operations (NTO) is responsible for our global production unit
-Novartis Business Services (NBS) focuses on internal services. – 显示更少